輔仁大學生物醫學暨藥學研究所Graduate Institute of Basic Medicine, Fu Jen Catholic University
師資陣容
師資陣容

 

教師姓名
 陳宜民
職 稱
 專任教授
分 機
 6251
E-mail
 150110@mail.fju.edu.tw
學 經 歷
1. 哈佛大學癌生物學系科學博士
2. 陽明醫學院微生物及免疫學所博士
3. 陽明大學愛滋病防治及研究中心教授兼任主任
4. 陽明大學微生物及免疫學研究所特聘教授
5. 陽明大學研究發展處研發長
6. 高雄醫學大學學術副校長
7. 立法院立法委員
8. 臺北醫學大學臨床藥物基因體暨蛋白質體學碩士學位學程教授
專 長
1. 腫瘤病毒學
2. 分子流行病學
3. 新藥開發
4. 基因體醫學
5. 健保大型資料庫分析
研究領域
1. HIV病毒學及分子流行病學
2. 探討GNMT在肝癌的治病機轉及角色
3. 基因體醫學
4. 健保大型資料庫分析
 
 
 
  著作
A. 學術期刊論文
1. Rajni K, Yang MH, Tseng CH, Yen, CH, Li WY, Tyan YC, Chen M, Chen YL*, Chen YM*. Discovery of an orally efficacious MYC inhibitor for liver cancer using GNMT-based high throughput screening system and structure-activity relationship analysis" J Med Chem. 2021. (in revision)

2. Ho TC, Wang YH, Chen YL, Tsai WC, Lee CH, Chuang KP, Chen YM, Yuan  CH, Ho SY, Yang MH*, Tyan YC*. Chloroquine and Hydroxychloroquine: Efficacy in the Treatment of the COVID-19. Pathogens, 10(2), 217, 2021) 
 
3. Yang MH, Chen SH, Chen KC, You HP, Wu HY, Chen YM, Huang YF, Huang MY, Yuan CH, Lin PH, Tyan YC. Quantitative analysis of progesterone using isotope dilution matrix-assisted laser desorption ionization-time of flight mass spectrometry as a reference procedure for radioimmunoassay. Clinica Chimica Acta, 512, 2021
 
4. Wu HC, Cheng MJ, Yen CH, Chen YM, Chen YS, Chen IS7, Chang HS.  Chemical Constituents with GNMT-Promoter-Enhancing and NRF2-Reduction Activities from Taiwan Agarwood Excoecaria formosana. Molecules, 25(7), 2020.
 
5. Wang WH, Yeh CS, Lin CY, Yuan RY, Urbina AN, Lu PL, Chen YH, Chen YM, Liu FT, Wang SF. Amino acid deletion in p6gag domain of HIV-1 CRF07_BC ameliorate galectin-3 mediated enhancement in viral budding. Int J Mol Sci, 21 (8); 2910, 2020.
 
6. Yang MH, Chen M, Mo HH, Tsai WC, Chang YC, Chang CC, Chen KC, Wu HY, Yuan CH, Lee CH, Chen YM*, Tyan YC*. Utilizing experimental mouse model to identify effectors of hepatocellular carcinoma induced by HBx antigen. Cancers (Basel), 12(2), 2020.
 
7. Li WY, Huang SW, Wang SF, Liu HF, Chou CH, Wu SJ, Huang HD, Lu PL, Fann CS, Chen M, Chen YH, Chen YM*. Source Identification of HIV-1 Transmission in Three Lawsuits Using Ultra-Deep Pyrosequencing and Phylogenetic Analysis. J Microbio Immuno Infec., 2020 Jan. 27. (Epub ahead of print)
 
8. Yang WS, Lin TY, Chang L, Yeh WW, Huang SC, Chen TY, Hsieh YT, Chen ST, Li WC, Pan CC, Campbell M, Yen CH, Chen YM, Chang P-C*. HIV-1 Tat Interacts with a Kaposi’s Sarcoma-Associated Herpesvirus Reactivation-Upregulated Antiangiogenic Long Noncoding RNA, LINC00313, and Antagonizes Its Function. J. Virol., 94(3), 2020. (Epub ahead of print Jan. 17, 2020.).
 
9. Chu TH, Huang ST, Yang SF, Li CJ, Lin HW, Weng BC, Yang SM, Huang SC, Wu JC, Chang YC, Wen ZH, Chen YM, Wu WJ, Kung ML, Tai PH, Wu DC, Tai MH. Hepatoma-derived growth factor participates in Helicobacter Pylori-induced neutrophils recruitment, gastritis and gastric carcinogenesis. Oncogene. 38(37):6461-6477, 2019.
 
10. Huang JW, Chen CJ, Yen CH, Chen YM, Liu YP. Loss of Glycine N-Methyltransferase Associates with Angiopoietin-Like Protein 8 Expression in High Fat-Diet-Fed Mice. Int J Mol Sci., 29: 20 (17), 2019.
 
11. Yang MH, Chen SC, Chen KC, You HP, Wu HY, Chen YM, Huang Y-F, Huang MY, Yuan CH, Lin PC, Tyan YC *. Quantitative analysis of progesterone using isotope dilutionmatrix-assisted laser desorption ionization-time of flight mass spectrometry as a reference procedure for radioimmunoassay. Clinica Chimica Acta., 2019. (Epub ahead of print)
 
12. Yang MH, Yen CH, Chen YF, Fang CC, Li CH, Lee KJ, Lin YH, Weng CH, Liu TT, Huang SF, Te BT and Chen YM*. Somatic mutations of PREX2 gene in patients with hepatocellular carcinoma. Sci Rep., 9(1), 2552, 2019.
 
13. Chen M, Yang MH, Chang MM, Tyan YC, Chen YM*. Tumor suppressor gene glycine N-methyltransferase and its potential in liver disorders and hepatocellular carcinoma. Toxicol Appl Pharmacol., 378,114607, 2019.
 
14. Yang MH, Liao CC, Lai XT, Yen CH, Chen YM*. Utilizing proteomic approach to identify nuclear translocation related serine kinase phosphorylation site of GNMT as downstream effector for benzo[a]pyrene. J Food Drug Anal., 27(2), 603-609, 2019.
 
15. Yen YF, Chen Marcelo, Jen IA, Chuang PH, Lee CY, Lin SI, Chen YM*. Short- and Long-term Risks of Highly Active Antiretroviral Treatment with Incident Opportunistic Infections among People Living with HIV/AIDS. Sci Rep., 9(1):3476, 2019
 
16. Kant R, Yen CH, Hung JH, Lu CK, Tung CY, Chang PC, Chen YH, Tyan YC ChenYM*. Induction of GNMT by 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranoside through proteasome-independent MYC downregulation in hepatocellular carcinoma. Sci Rep., 9(1):1968, 2019.
 
17. Fang CC, Wu CF, Liao YJ, Huang SF, Chen Marcelo, Chen YM*. AAV serotype 8-mediated liver specific GNMT expression delays progression of hepatocellular carcinoma and prevents carbon tetrachloride-induced liver damage. Sci Rep., 8(1):13802, 2018.
 
18. Liu YP *, Chen CH, Yen CH, Chen CJ, Chen YM, MS Huang*. HIV1 Tat with TIP30 promotes metastasis by enhancing the nuclear translocation of Snail in non-small cell lung cancer. Cancer Sci. 109(10):3105-3114, 2018
 
19. Yen YF, Jen IA, Chuang PH, Chen M, Lan YC, Lee CY, Arthur Chen YM*. Association of highly active antiretroviral treatment with incident tuberculosis in people living with HIV/AIDS. Ann Epidemiol., 28(12):886-892.e3, 2018.
 
20. Li W-Y, Marcelo Chen, Hung SW, Jen IA, Wang SF, Yang JY, Chen YH, Chen YM*. Molecular Epidemiology Study of HIV-1 Infection among Men Who Have Sex with Men in Taiwan from 2013 to 2015. PLoS One., 6;13(12), 2018.
 
21. Hung JH, Li CH, Yeh CH, Huang PC, Fang CC, Chen YF, Lee KJ, Chou CH, Cheng HY, Huang HD, Chen Marcelo, Lin Anya MY, Tsai TF, Yen CH, Tsou AP, Tyan YC, Chen YM*. MicroRNA-224 down-regulates Glycine N-methyltransferase gene expression in Hepatocellular Carcinoma. Sci Rep., 8(1):12284, 2018.
 
22. Lee CY, Jen IA, Yen YF, Chen Marcelo, Chen YM*. Association of Highly Active Antiretroviral Treatment with Incident Tuberculosis in People Living with HIV/AIDS. Ann Epidemiol., 28(12):886-892, 2018.
 
B. 學術會議論文
1. 

2. 

3.
 
 
  近五年來研究計畫
1. 科技部計畫:建立新型平台以從事新型冠狀病毒的免疫學分析、藥物篩選及疫苗開發-功能性分析新型冠狀病毒感染者周邊免疫細胞與臨床表徵之研究(1/3)。2020/11/01~2021/10/31(共同主持人)
2. 輔技部計畫:利用果蠅和小鼠模式研發可延長壽命並改善健康狀況之天然植物萃取物。2018/04/01~2019/07/31(共同主持人)
3. 科技部計畫: 建立適用於高通量藥物篩選之天然物純化劃分層藥庫(2/2)。 2018/01/01~2019/03/31(共同主持人)
4. 科技部計畫: 氧化還原狀態在肉瘤狀肝細胞癌形成過程之角色及在抗肝癌藥物開發之應用。2015/08/01~2018/07/31(共同主持人)
5. 產學合作—銀嘉科技股份有限公司:ACT抗菌材料之抗病毒功效試驗與機轉探討。2021/01/01~2021/12/31)
6. 產學合作—澤生生技股份有限公司:植物萃取物於脂肪肝細胞模式之可能療效測定及其可能機轉研究計畫。2020/08/01~2021/01/31
7. 科技部計畫—提升私校研發能量專案計畫:肝癌抑癌基因GNMT功能之定性與調控機轉之研究(2/3)。20150801~20170731(計畫主持人)
8. 科技部計畫—國家型科技計畫:發展具調控苷胺酸氮甲基轉移酶表現之小分子先導藥物作為抗肝癌之治療(2/2)。20150501~20160430(計畫主持人)
 
  研究室簡介
補述中。

                                                                                                                                                   

 


Copyright c2009 Graduate Institute of Biomedical and Pharmaceutical Science 輔仁大學生物醫學暨藥學研究所
所辦電話:02-29053426所長電話:02-29053412Email:GIBPS@mail.fju.edu.tw